|
Market Closed -
London S.E.
11:35:12 2026-08-17 am EDT
|
5-day change | 1st Jan Change | ||
| 11,560.00 GBX | +0.87% |
|
-3.59% | -16.17% |
| 12:18pm | FTSE 100 falls for sixth day in a row as consumer stocks weigh | RE |
| 11:48am | UK Shares Start Week Downbeat; AstraZeneca Shares Data from Lung Cancer Trials | MT |
Chart: Technical Analysis
Stock exchange
London S.E.
AZN 11,560.00 p
+0.87%
25.1B
p
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| AZN | 156.40USD | -0.03% | 259M $ | |
London S.E.
| AZN | 11,560.00GBX | +0.87% | 25.1B p | |
NYSE
| AZN | 156.45USD | -0.50% | 579M $ | |
Nasdaq Stockholm
| AZN | 1,489.00SEK | +0.61% | 1.24B kr | |
CBOE
| AZN | 11,544.00GBX | +0.61% | 4.8B p | |
CBOE
| AZNs | 1,485.50SEK | +0.47% | 398M kr | |
CBOE
| AZN | 156.03USD | -0.26% | 12.22M $ | |
CBOE
| AZN | 1,485.50SEK | +0.64% | 12.57M kr | |
Tradegate
| ZEG | 135.10EUR | -0.11% | 969K € | |
Boerse Muenchen
| ZEG | 135.15EUR | +0.15% | 241K € | |
Deutsche Boerse AG
| ZEG | 136.00EUR | +1.00% | 216K € | |
Börse Stuttgart
| ZEG | 134.80EUR | +0.11% | 113K € | |
Mexican S.E.
| AZN1 N | 2,699.00MXN | -1.50% | 688K $ | |
Berne S.E.
| 000982352 | 127.75CHF | -0.79% | 766.51 CHF | |
Buenos Aires S.E.
| AZN | 61,550.00ARS | -1.01% | 18.46M $ | |
Buenos Aires S.E.
| AZND | 40.60USD | -0.90% | 2.72K $ | |
Sao Paulo
| A1ZN34 | 135.00BRL | -0.70% | 945 R$ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 12,628 | 13,134 | 15,542 |
| Spread/Res. | -8.46% | -11.98% | -25.62% |
| Spread/Supp. | +12.98% | +12.98% | +5.09% |
| Support | 10,232 | 10,232 | 11,000 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AZN Stock
- Charts AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions

















